The actions of cholinergic drugs on motor nerve terminals

The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals.

British journal of pharmacology·2003

Nicotinic acid adenine dinucleotide phosphate enhances quantal neurosecretion at the frog neuromuscular junction: possible action on synaptic vesicles in the releasable pool.

Molecular pharmacology·2001

Inositol trisphosphate and cyclic adenosine diphosphate-ribose increase quantal transmitter release at frog motor nerve terminals: possible involvement of smooth endoplasmic reticulum.

Neuroscience·2000

Effect of hypertonicity on augmentation and potentiation and on corresponding quantal parameters of transmitter release.

Journal of neurophysiology·1999

Angiotensin II and related peptides alter liposomal membrane fluidity.

Biochemistry and molecular biology international·1998

Real-time detection of mitochondrial inhibition at frog motor nerve terminals using increases in the spatial variance in probability of transmitter release.

Neuroscience letters·1995

Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma.

Pharmacological reviews·2026

Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases.

Pharmacological reviews·2026

Chronic pain in Alzheimer disease and the role of neuroimmune interactions.

Pharmacological reviews·2026

Renal aging and associated diseases: Common mechanisms and therapeutic approaches.

Pharmacological reviews·2026

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.

Pharmacological reviews·2026

Exploration of multifunctional characteristics and regulatory mechanism of promoter G-quadruplexes.

Pharmacological reviews·2026

A meta-analysis of periodic and aperiodic electrophysiological features in Parkinson's disease.

Brain communications·2026

RBPMS::NTRK3-rearranged sacral malignant spindle cell tumor in neurofibromatosis diagnosed by RNA sequencing: a case report and literature review.

Frontiers in medicine·2026

Gut Microbiota, Neuroinflammation, and Autonomic Dysfunction in Neurodegenerative Diseases: A Systematic Review of Mechanistic and Translational Evidence.

Cureus·2026

The metastatic spectrum in functional and non-functional NENs: mechanistic insights from multi-omics.

Frontiers in endocrinology·2026

"Internal carotid artery-type cervical spondylosis" is not supported as an independent subtype: a perspective on diagnostic classification and clinical differentiation.

Frontiers in neurology·2026

POEMS syndrome presenting as presumed chronic glomerulonephritis with a 1-year delay in diagnosis: a case report.

Frontiers in medicine·2026

Related Experiment Videos

The actions of cholinergic drugs on motor nerve terminals

Related Concept Videos

The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals.

Nicotinic acid adenine dinucleotide phosphate enhances quantal neurosecretion at the frog neuromuscular junction: possible action on synaptic vesicles in the releasable pool.

Inositol trisphosphate and cyclic adenosine diphosphate-ribose increase quantal transmitter release at frog motor nerve terminals: possible involvement of smooth endoplasmic reticulum.

Effect of hypertonicity on augmentation and potentiation and on corresponding quantal parameters of transmitter release.

Angiotensin II and related peptides alter liposomal membrane fluidity.

Real-time detection of mitochondrial inhibition at frog motor nerve terminals using increases in the spatial variance in probability of transmitter release.

Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma.

Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases.

Chronic pain in Alzheimer disease and the role of neuroimmune interactions.

Renal aging and associated diseases: Common mechanisms and therapeutic approaches.

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.

Exploration of multifunctional characteristics and regulatory mechanism of promoter G-quadruplexes.

A meta-analysis of periodic and aperiodic electrophysiological features in Parkinson's disease.

RBPMS::NTRK3-rearranged sacral malignant spindle cell tumor in neurofibromatosis diagnosed by RNA sequencing: a case report and literature review.

Gut Microbiota, Neuroinflammation, and Autonomic Dysfunction in Neurodegenerative Diseases: A Systematic Review of Mechanistic and Translational Evidence.

The metastatic spectrum in functional and non-functional NENs: mechanistic insights from multi-omics.

"Internal carotid artery-type cervical spondylosis" is not supported as an independent subtype: a perspective on diagnostic classification and clinical differentiation.

POEMS syndrome presenting as presumed chronic glomerulonephritis with a 1-year delay in diagnosis: a case report.

Related Experiment Videos

The actions of cholinergic drugs on motor nerve terminals

Related Concept Videos

Related Articles